Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy.
about
mTOR referees memory and disease through mRNA repression and competition.mTOR Cross-Talk in Cancer and Potential for Combination Therapy.A randomized control trial to establish the feasibility and safety of rapamycin treatment in an older human cohort: Immunological, physical performance, and cognitive effects.Therapeutic Targeting of mTOR in T-Cell Acute Lymphoblastic Leukemia: An UpdateMYO18B promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR signaling pathway
P2860
Molecular Pathways: Increased Susceptibility to Infection Is a Complication of mTOR Inhibitor Use in Cancer Therapy.
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@ast
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@en
type
label
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@ast
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@en
prefLabel
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@ast
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@en
P2093
P2860
P1476
Molecular Pathways: Increased ...... hibitor Use in Cancer Therapy.
@en
P2093
Adrian M Eiden
Beverly A Mock
John K Simmons
Joy M Gary
Shuling Zhang
P2860
P304
P356
10.1158/1078-0432.CCR-14-3239
P407
P577
2015-11-25T00:00:00Z